Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS Jr, Charlton M; ASTRAL-4 Investigators. Curry MP, et al. N Engl J Med. 2015 Dec 31;373(27):2618-28. doi: 10.1056/NEJMoa1512614. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26569658 Free article. Clinical Trial.
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.
Lai JC, Verna EC, Brown RS Jr, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Lai JC, et al. Hepatology. 2011 Aug;54(2):418-24. doi: 10.1002/hep.24390. Epub 2011 Jun 23. Hepatology. 2011. PMID: 21538434 Free PMC article.
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.
O'Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Thacker LR, Bajaj JS; North American Consortium for the Study of End-Stage Liver Disease. O'Leary JG, et al. Clin Gastroenterol Hepatol. 2015 Apr;13(4):753-9.e1-2. doi: 10.1016/j.cgh.2014.07.060. Epub 2014 Aug 12. Clin Gastroenterol Hepatol. 2015. PMID: 25130937 Free PMC article. Clinical Trial.
Hepatitis C genotype influences post-liver transplant outcomes.
Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Campos-Varela I, et al. Transplantation. 2015 Apr;99(4):835-40. doi: 10.1097/TP.0000000000000413. Transplantation. 2015. PMID: 25211520 Free PMC article.
A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be.
Wong F, O'Leary JG, Reddy KR, Kamath PS, Garcia-Tsao G, Maliakkal B, Subramanian R, Thacker L, Bajaj J; North American Consortium for the Study of End-Stage Liver Disease. Wong F, et al. J Hepatol. 2015 Mar;62(3):741-3. doi: 10.1016/j.jhep.2014.10.047. Epub 2014 Dec 5. J Hepatol. 2015. PMID: 25485798 Free article. No abstract available.
High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
Reddy KR, O'Leary JG, Kamath PS, Fallon MB, Biggins SW, Wong F, Patton HM, Garcia-Tsao G, Subramanian RM, Thacker LR, Bajaj JS; North American Consortium for the Study of End-Stage Liver Disease. Reddy KR, et al. Liver Transpl. 2015 Jul;21(7):881-8. doi: 10.1002/lt.24139. Liver Transpl. 2015. PMID: 25845966 Free article.
143 results